Melanogray is a topical active marketed for reducing hyperpigmentation by interfering with melanin synthesis and distribution. It is typically used in formulations targeting dark spots, melasma, and uneven skin tone.
| Reported effect | How often | Notes |
|---|---|---|
| Mild skin irritation (redness, stinging) | Common | Usually transient and occurs during early use or at higher concentrations. |
| Dryness or flaking | Common | Often manageable with concurrent moisturizer use. |
| Contact dermatitis | Uncommon | May present as itching or rash; discontinue if persistent. |
| Increased photosensitivity | Uncommon | Sunscreen use is advised during treatment. |
| Paradoxical hyperpigmentation or uneven lightening | Rare | Reported with overuse or prolonged application. |
| Allergic hypersensitivity reaction | Very rare | Severe reactions warrant immediate discontinuation and medical attention. |
Frequencies reflect typical cosmetic use reported in the literature, not a guarantee for your skin.